We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.95B
AUM Growth
+$323M
Cap. Flow
+$326M
Cap. Flow %
8.24%
Top 10 Hldgs %
35.62%
Holding
121
New
38
Increased
29
Reduced
19
Closed
34

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$89M
2
HCA icon
HCA Healthcare
HCA
+$87.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$86.2M
4
ELV icon
Elevance Health
ELV
+$82.1M
5
VMW
VMware, Inc
VMW
+$73.4M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$100M
2
MCK icon
McKesson
MCK
+$82.1M
3
SYK icon
Stryker
SYK
+$68M
4
PFE icon
Pfizer
PFE
+$67.6M
5
GILD icon
Gilead Sciences
GILD
+$63.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.61%
2 Technology 10.42%
3 Communication Services 8.14%
4 Industrials 7%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
26
Heron Therapeutics
HRTX
$86.3M
$56.4M 1.43%
+1,811,166
New +$34.1M
MTG icon
27
MGIC Investment
MTG
$6.27B
$56.2M 1.42%
4,939,737
+1,025,471
+26% +$11M
NOW icon
28
ServiceNow
NOW
$102B
$55.1M 1.39%
+3,705,020
New +$57.1M
ILMN icon
29
Illumina
ILMN
$29.4B
$53.2M 1.35%
250,575
-134,781
-35% -$26.3M
RDUS
30
DELISTED
Radius Health, Inc.
RDUS
$51.7M 1.31%
763,296
+34,316
+5% +$1.6M
UNH icon
31
UnitedHealth
UNH
$382B
$51.6M 1.31%
423,064
-362,681
-46% -$42.9M
CTSH icon
32
Cognizant
CTSH
$21.5B
$49.8M 1.26%
815,408
+815,358
+1,630,716% +$51.2M
LNKD
33
DELISTED
LinkedIn Corporation
LNKD
$47.6M 1.21%
+230,445
New +$51.4M
RAD
34
DELISTED
Rite Aid Corporation
RAD
$46.9M 1.19%
280,930
+7,289
+3% +$1.22M
HAL icon
35
Halliburton
HAL
$27.9B
$46.7M 1.18%
1,084,974
+731,745
+207% +$33.7M
QRVO icon
36
Qorvo
QRVO
$7.63B
$46.2M 1.17%
+575,266
New +$44.6M
JD icon
37
JD.com
JD
$40.8B
$45.4M 1.15%
+1,331,131
New +$45.3M
BHC icon
38
Bausch Health
BHC
$1.65B
$43.7M 1.11%
196,511
-452,531
-70% -$100M
FLS icon
39
Flowserve
FLS
$9.25B
$41.3M 1.04%
+783,767
New +$43.7M
ALDR
40
DELISTED
Alder Biopharmaceuticals
ALDR
$39.9M 1.01%
753,281
+122,815
+19% +$4.47M
MDCO
41
DELISTED
Medicines Co
MDCO
$37.3M 0.94%
+1,302,516
New +$36.3M
KYTH
42
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$37.1M 0.94%
492,846
-749,663
-60% -$40.2M
AERI
43
DELISTED
Aerie Pharmaceuticals
AERI
$32.7M 0.83%
1,851,564
+1,616,119
+686% +$29.6M
THOR
44
DELISTED
THORATEC CORPORATION
THOR
$32.5M 0.82%
730,074
+164,275
+29% +$7.19M
VAR
45
DELISTED
Varian Medical Systems, Inc.
VAR
$30.9M 0.78%
417,302
-143,276
-26% -$11.2M
ARAY icon
46
Accuray
ARAY
$28.4M
$29.8M 0.76%
4,428,261
+1,530,551
+53% +$11.4M
ACOR
47
DELISTED
Acorda Therapeutics
ACOR
$27.2M 0.69%
6,812
+2,935
+76% +$11.3M
OREX
48
DELISTED
Orexigen Therapeutics, Inc.
OREX
$26.1M 0.66%
527,867
+240,818
+84% +$14.4M
ZSPH
49
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$23.6M 0.6%
451,071
-433,504
-49% -$21.3M
HDP
50
DELISTED
Hortonworks, Inc.
HDP
$22.5M 0.57%
889,179
+520,198
+141% +$12.5M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2015 Portfolio in Review

As of Q2 2015, PFM Health Sciences held 121 positions worth $3.95B, up 8.9% from $3.63B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

PFM Health Sciences deployed $326M of net new capital in Q2 2015, opening 38 new positions and adding to 29 existing holdings. Its largest new stake was Aetna Inc: 779,930 shares worth $99.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bausch Health, an estimated $100M trimmed.

  • PFM Health Sciences's largest Q2 2015 buy was Aetna Inc: 779,930 shares worth $99.4M.
  • PFM Health Sciences added most to HCA Healthcare in Q2 2015, an estimated $87.3M increase.
  • PFM Health Sciences's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $100M.
  • PFM Health Sciences fully exited McKesson in Q2 2015, selling an estimated $82.1M.
  • PFM Health Sciences's ten largest holdings make up 36% of its $3.95B portfolio in Q2 2015.
  • PFM Health Sciences opened 38 new positions and closed 34 in Q2 2015.
  • PFM Health Sciences's portfolio value rose 8.9% quarter-over-quarter to $3.95B.

Based on PFM Health Sciences's 13F filing for Q2 2015, filed 14 Aug 2015.